Breaking News Instant updates and real-time market news.

AVGO

Broadcom

$254.87

-12.89 (-4.81%)

, QCOM

Qualcomm

$60.62

0.73 (1.22%)

09:09
03/17/18
03/17
09:09
03/17/18
09:09

Broadcom Plan B looks complicated, Barron's says

After Broadcom's (AVGO) bid for Qualcomm (QCOM) ended last week after President Trump blocked it on grounds of national security, the Wall Street now wants to know what the former will try to buy as plan B, Tiernan Ray writes in this week's edition of Barron's. The two most heavily speculated-about targets are Xilinx (XLNX) and Micron Technology (MU), he notes, adding that several others are conceivable, including Microchip Technology (MCHP), Marvell Technology Group (MRVL), Maxim Integrated Products (MXIM), and Analog Devices (ADI). However, with nearly $18B in 2017 revenue, Broadcom is big enough to make finding targets that matter challenging, he contends. Reference Link

AVGO

Broadcom

$254.87

-12.89 (-4.81%)

QCOM

Qualcomm

$60.62

0.73 (1.22%)

XLNX

Xilinx

$76.03

0.2 (0.26%)

MU

Micron

$60.58

1.74 (2.96%)

MCHP

Microchip

$98.18

0.65 (0.67%)

MRVL

Marvell

$23.18

-0.01 (-0.04%)

MXIM

Maxim Integrated

$62.62

0.25 (0.40%)

ADI

Analog Devices

$94.15

0.21 (0.22%)

  • 22

    Mar

  • 22

    Mar

  • 23

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

  • 21

    May

  • 30

    May

AVGO Broadcom
$254.87

-12.89 (-4.81%)

03/16/18
WELS
03/16/18
INITIATION
Target $260
WELS
Market Perform
Broadcom resumed with a Market Perform at Wells Fargo
Wells Fargo analyst David Wong resumed coverage of Broadcom with a Market Perform rating and $260 price target. The possibility that Broadcom will find it increasingly difficult to make large acquisitions and that dollar content increases in smartphones might slow creates some concerns for the stock, Wong tells investors in a research note.
03/16/18
CHLM
03/16/18
NO CHANGE
Target $330
CHLM
Buy
Broadcom 'on the hunt' for additional, smaller M&A, says Craig-Hallum
Craig-Hallum analyst Tony Stoss reiterated his Buy rating and $330 price target on Broadcom (AVGO) following the company's in-line Q1 results and guidance. In a research note to investors, Stoss said he is confident in Broadcom's content at Apple (AAPL) longer term as management stated they expect to grow Apple content about 15% annually for the next 3-5 years. Additionally, Stoss noted that while the company is "disappointed" that the deal with Qualcomm (QCOM) was blocked, Broadcom remains "on the hunt" for additional M&A, which will likely be smaller in size given that the company plans to use just cash on hand to fund additional acquisitions.
03/16/18
RHCO
03/16/18
NO CHANGE
Target $345
RHCO
Buy
Broadcom price target raised to $345 from $335 at SunTrust
SunTrust analyst William Stein raised his price target on Broadcom to $345 after the company's latest earnings beat and raised outlook, which "overwhelm" the headwinds of higher taxes from redomiciliation. Stein also cites the management's target leverage remaining below 2-times, suggesting "more easily digestible deals" in M&A putting some investor concerns at ease. The analyst keeps his Buy rating on Broadcom, adding that his new valuation reflects in part no incremental M&A over the near term.
03/16/18
OPCO
03/16/18
NO CHANGE
Target $315
OPCO
Outperform
Broadcom's Q1 results show resiliency of company's model, says Oppenheimer
Following its Q1 results, Oppenheimer analyst Rick Schafer told investors in a research note that he believes Broadcom (AVGO) has one of the most "strategically and financially attractive business models" in semiconductors, and that its "positive" results in the face of weaker optical, iPhone and carrier access markets shows the resiliency of the company's model and management's ability to drive "enviable" growth and profitability in many business environments. Now that Broadcom is "past the Qualcomm (QCOM) saga," Schafer expects Broadcom to return to its playbook, finding and executing "bite-sized" accretive acquisitions. Schafer, who has an Outperform rating on Broadcom, says he is a "long-term buyer" with a $315 price target.
QCOM Qualcomm
$60.62

0.73 (1.22%)

03/16/18
DADA
03/16/18
NO CHANGE
Target $325
DADA
Buy
Broadcom has several growth prospects for next couple years, says DA Davidson
DA Davidson analyst Thomas Diffely kept his Buy rating and $325 price target on Broadcom (AVGO) after the company's Q1 earnings beat that was driven by the "extended iPhone X rollout, content growth at Apple (AAPL), and an extra week in the quarter." Despite the broken Qualcomm (QCOM) deal, the analyst contends that content growth at smartphone manufacturers, strong trends in the data center segment, and the emergence of 5G combine to give Broadcom growth prospects for the next couple of years.
03/16/18
WELS
03/16/18
INITIATION
Target $65
WELS
Market Perform
Qualcomm resumed with a Market Perform at Wells Fargo
Wells Fargo analyst David Wong resumed coverage of Qualcomm with a Market Perform rating and $65 price target. The analyst sees risks to Qualcomm shares from slowing growth in the smartphone end market and the possibility that the company might fail to achieve a positive resolution to the current licensing disputes or that new disputes might arise with other licensing customers.
XLNX Xilinx
$76.03

0.2 (0.26%)

01/25/18
FBCO
01/25/18
NO CHANGE
Target $85
FBCO
Outperform
Xilinx price target raised to $85 from $75 at Credit Suisse
Credit Suisse analyst John Pitzer raised his price target for Xilinx to $85 from $75 following better than expected quarterly results. The analyst reiterates an Outperform rating on the shares.
01/25/18
RHCO
01/25/18
NO CHANGE
Target $79
RHCO
Hold
Xilinx price target raised to $79 from $69 at SunTrust
SunTrust analyst William Stein raised his price target on Xilinx to $79 and kept his Hold rating after Q3 earnings. Stein notes that while revenues excluding Comms and Data Center sales continued to outperform amid 20% annual growth in automotive and the emerging exposure to cryptocurrencies, Comms and Data end market underperformed again and may remain challenging until 5G fully launches around 2020.
03/13/18
KEYB
03/13/18
NO CHANGE
KEYB
Broadcom could look at Micron next with Qualcomm blocked, says KeyBanc
President Trump's order to block Broadcom's (AVGO) proposed takeover of Qualcomm (QCOM) also likely blocks the possibility of the company trying to acquire any other player with any military/defense exposure, such as Xilinx (XLNX), KeyBanc analyst John Vinh tells investors. However, he expects Broadcom to remain acquisitive and thinks Micron (MU) could be another potential target, citing a lack of security concerns and Broadcom's previous attempts to bid for Toshiba (TOSBF), he noted. Vinh reiterates his Overweight rating and $320 price target on Broadcom, adding that he sees the executive order as a "slight positive," since it removes a near-term distraction and overhang.
02/22/18
RBCM
02/22/18
NO CHANGE
Target $325
RBCM
Top Pick
RBC finds takeover targets for Broadcom should Qualcomm deal fail
RBC Capital analyst Amit Daryanani finds it prudent to think about other takeover options for Broadcom (AVGO) should its attempt to acquire Qualcomm (QCOM) fail. Broadcom is in a "unique position" as it generates $9B-$10B of free cash flow annually, has balance sheet that is "almost net debt neutral" and a management team "that has impeccable history in integrating assets," Daryanani tells investors in a research note titled "If not QCOM, Who Is Next?" The analyst sees potential targets in Xilinx (XLNX), Analog Devices (ADI), Maxim Integrated (MXIM), Marvell Technology (MRVL) and Microsemi (MSCC). Daryanani keeps a Top Pick rating on Broadcom with a $325 price target. He believes the company has the ability to sustain double-digit growth with or without Qualcomm.
MU Micron
$60.58

1.74 (2.96%)

03/16/18
JPMS
03/16/18
NO CHANGE
Target $60
JPMS
Overweight
JPMorgan says stay long Micron into February quarter earnings
JPMorgan analyst Harlan Sur tells investors to stay long Micron Technology into the company's February quarter earnings report. Micron is executing well in a solid demand environment while capacity expansion remains disciplined, Sur tells investors in a research note. He expects the stock will continue outperforming as supply of DRAM remains "tight/balanced through 2018." The analyst keeps an Overweight rating on Micron shares with a $60 price target.
03/16/18
BARD
03/16/18
NO CHANGE
Target $100
BARD
Outperform
Micron price target raised to $100 from $60 at Baird
Baird analyst Tristan Gerra raised his price target on Micron to $100 from $60 based on stronger than expected memory trends. He saw a significant increase in contract pricing for DRAM, while NAND reductions were more muted than expected. Gerra reiterated his Outperform rating on Micron shares.
03/16/18
KEYB
03/16/18
NO CHANGE
Target $65
KEYB
Overweight
KeyBanc views call with Samsung as positive for Micron
KeyBanc analyst Weston Twigg spoke to Samsung (SSNLF) last night and gained more clarity on the company's DRAM expansion plans for 2018. Samsung, which represents 35%-40% of DRAM production, indicated that it may grow its net DRAM wafer starts per month by around 10% for the year, and that it would likely exit 2018 at a slightly higher rate than that, Twigg tells investors in a research note. He believes, however, that bit growth won't likely exceed market demand and should be moderate. As such, the analyst expects a "prolonged healthy DRAM pricing environment," which he views as positive for Micron Technology (MU). Twigg has an Overweight rating on the shares with a $65 price target.
MCHP Microchip
$98.18

0.65 (0.67%)

03/06/18
PIPR
03/06/18
DOWNGRADE
Target $68.78
PIPR
Neutral
Microsemi downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Harsh Kumar downgraded Microsemi (MSCC) to Neutral citing the pending takeover by Microchip (MCHP). The analyst does not believe another company will try to outbid Microchip's current agreement with Microsemi. He lowered his price target for Microsemi shares to $68.78 from $70 and expects the deal will close in Q2.
03/05/18
MZHO
03/05/18
UPGRADE
MZHO
Buy
Microchip upgraded to Buy from Neutral at Mizuho
Mizuho analyst Vijay Rakesh upgraded Microchip (MCHP) to Buy from Neutral with a $110 price target. Rakes expects the Microsemi (MSCC) acquisition will drive Microchip's 2019-2020 earnings of $7-$8 and sees an opportunity for the company to drive breadth and operating leverage with the transaction.
03/05/18
BMOC
03/05/18
DOWNGRADE
Target $68.78
BMOC
Market Perform
Microsemi downgraded to Market Perform from Outperform at BMO Capital
BMO Capital analyst Ambrish Srivastava downgraded Microsemi (MSCC) to Market Perform from Outperform following the bid by Microchip (MCHP) at $68.78 per share. Srivastava adds that he does anticipate a potential competitive bid for the company.
03/08/18
GSCO
03/08/18
UPGRADE
Target $108
GSCO
Buy
Microchip upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Mark Delaney upgraded Microchip to Buy and raised his price target for the shares to $108 from $88. The analyst believes the company's capital allocation could drive earnings growth and views the valuation as reasonable at current share levels.
MRVL Marvell
$23.18

-0.01 (-0.04%)

03/12/18
NEED
03/12/18
NO CHANGE
Target $27
NEED
Buy
Marvell growth across core businesses is encouraging, says Needham
Needham analyst N. Quinn Bolton keeps his Buy rating and $27 price target on Marvell (MRVL) after the company's "slightly above expectations" Q4 results and above-consensus Q1 outlook. Bolton says the Q4 report suggests "traction in new enterprise and data center products and strength in the SSD controller family", while modest sequential revenue growth in Networking and the progressing accretive Cavium (CAVM) acquisition with cost synergies of up to $175M add to his bullish view.
03/14/18
RILY
03/14/18
NO CHANGE
Target $30
RILY
Buy
Marvell selloff yesterday a buying opportunity, says B. Riley FBR
B. Riley FBR analyst Craig Ellis views yesterday's pullback in shares of Marvell Technology Group (MRVL) after President Trump blocked Broadcom's (BRCM) attempted acquisition of Qualcomm (QCOM) as a buying opportunity. The analyst keeps a Buy rating on the shares with a $30 price target.
03/12/18
ARGS
03/12/18
NO CHANGE
Target $28
ARGS
Buy
Marvell remains undervalued on cash flow growth prospects, says Argus
Argus analyst Jim Kelleher keeps his Buy rating and a $28 price target on Marvell, writing the company has improved its execution through focus on value-added opportunities. The analyst also believes that while the stock price has moved higher, Marvell's valuation remains attractive relative to that of peers and considering the company's cash flow growth potential.
03/13/18
BNCH
03/13/18
NO CHANGE
BNCH
Buy
Marvell-Cavium deal in focus after denial of Broadcom-Qualcomm, says Benchmark
After President Trump signed an order prohibiting Broadcom's (AVGO) attempt to take over Qualcomm (QCOM), Benchmark analyst Gary Mobley said the news may cause investors to question CFIUS approval for the planned tie-up of Marvell (MRVL) with Cavium (CAVM). It is possible Marvell may have to re-domicile in the U.S. from Bermuda, which may delay the merger by a few months and would increase Marvell's tax rate unfavorably, he said. Mobley, who think it is hard to say whether the President will shoot down the deal, noted that CFIUS and China's MOFCOM are the last two regulatory hurdles for Marvell and Cavium's deal. He has a Buy rating on Marvell shares.
MXIM Maxim Integrated
$62.62

0.25 (0.40%)

02/28/18
02/28/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Celgene (CELG) downgraded to Hold from Buy at SunTrust by analyst Yatin Suneja after the company received a refusal to file letter from the FDA on ozanimod for relapsing forms of multiple sclerosis. Suneja said that following pipeline setbacks in late 2017, ozanimod was central to his "bull thesis to re-accelerate growth" and provide "much needed diversification away from myeloma." Given the delay, he lowered his ozanimod peak sales estimate to $3.5B from $5B. The refusal to file letter could result in a 24-month or longer delay for ozanimod's launch in relapsing forms of multiple sclerosis, Suneja said. 2. Frontier Communications (FTR) downgraded to Hold from Buy at Jefferies by analyst Scott Goldman. With the dividend now suspended and EBITDA stabilization "still a work in progress," the shares have no near-term catalyst, Goldman said. He believes "significant challenges" remain for Frontier following the dividend suspension. 3. Comcast (CMCSA, CMCSK) downgraded to Neutral from Outperform at Macquarie by analyst Amy Young, who cited uncertainty around the M&A playbook and increased net leverage. Young said Comcast's intention to acquire Sky (SKYAY) diversifies its portfolio and increases international revenues to 25% of total from 9% currently, but exposes it to satellite TV, which faces secular pressures. The analyst views the 12x price tag for Sky as high, questions the synergies, and believes the unpredictability could cap near-term upside. 4. e.l.f. Beauty (ELF) downgraded to Market Perform from Outperform at BMO Capital by analyst Shannon Coyne, who cited the "near-term challenges in the mass category" and heightened competition yielding further pressure on results and the stock in the near term. The analyst also points to the management having lowered its expectations for the 3rd time in 6 months, adding that it may take some time for investor confidence to return. Despite the downgrade, the analyst believes that e.l.f "has material white space in existing and new retailers" as well as an "unmatched strong value proposition." 5. Maxim Integrated (MXIM) downgraded to Neutral from Outperform at Macquarie by analyst Srini Pajjuri, who said shares have significantly outperformed the SOX index year-to-date and believes healthy fundamentals are now backed in, combined with some M&A premium. Pajjuri believes further upside is limited on a fundamental basis and believes comps will get tougher in the second half of 2018 and sees risk of higher volatility in Consumer as Samsung GS9 builds fade. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/28/18
MACQ
02/28/18
DOWNGRADE
MACQ
Neutral
Maxim Integrated downgraded to Neutral from Outperform at Macquarie
Macquarie analyst Srini Pajjuri downgraded Maxim Integrated to Neutral citing valuation and raised its price target to $64 from $62. The analyst said said shares have significantly outperformed the SOX index year-to-date and believes healthy fundamentals are now backed in, combined with some M&A premium. Pajjuri believes further upside is limited on a fundamental basis and believes comps will get tougher in 2H 2018 and sees risk of higher volatility in Consumer as Samsung GS9 builds fade.
01/30/18
01/30/18
UPGRADE
Target $60

Equal Weight
Maxim Integrated upgraded to Equal Weight amid M&A headlines at Morgan Stanley
As previously reported, Morgan Stanley analyst Craig Hettenbach upgraded Maxim Integrated to Equal Weight from Underweight, contending that M&A headlines, such as those yesterday from CNBC, likely put a floor under the stock. He increased his price target on Maxim to $60 from $47, which he notes is below the rumored bid of $70 per share, as Hettenbach believes that if a deal is not announced the stock would have downside to $52 per share. Maxim closed up 12% yesterday at $66.27 per share, but is sliding in pre-market back to near $59 per share after Japan's Renesas said last night that it is not the source of CNBC's takeover report and called the report not true.
ADI Analog Devices
$94.15

0.21 (0.22%)

03/01/18
ARGS
03/01/18
NO CHANGE
Target $110
ARGS
Buy
Analog Devices price target raised to $110 from $100 at Argus
Argus analyst Jim Kelleher raised his price target on Analog Devices (ADI) to $110, saying the stock price was pressured despite the Q1 earnings beat and a 7% hike in dividend. Kelleher adds that any weakness should be seen as a buying opportunity, with the stock trading at an attractive valuation. Longer term, the analyst keeps his Buy rating, stating that Analog Devices is benefiting from multiple positives, including "strong global demand for analog chips, rising analog applications and content in the industrial and automotive end markets and (being) a top consumer customer in Apple (AAPL)".
03/01/18
RILY
03/01/18
NO CHANGE
Target $122
RILY
Buy
Analog Devices price target raised to $122 from $113 at B. Riley FBR
B. Riley FBR analyst Craig Ellis raised his price target for Analog Devices to $122 and reiterates a Buy rating on the shares following the company's Q1 results. The analyst increased his estimates post the results.
02/23/18
OPCO
02/23/18
NO CHANGE
Target $100
OPCO
Outperform
Oppenheimer backs Outperform rating on Analog Devices ahead of Q1 report
Oppenheimer analyst Rick Schafer reiterated his Outperform rating and $100 price target on Analog Devices ahead of the company's first quarter results next week. In a research note to investors, he called the company "the industry's leading high-performance analog pure play," and sees a beat/raise set-up vs. the consensus on continued momentum in auto and industrial, which represents 62% of combined sales, and self-help margin improvement.
03/01/18
BMOC
03/01/18
NO CHANGE
Target $107
BMOC
Outperform
Analog Devices price target raised to $107 from $100 at BMO Capital
BMO Capital analyst Ambrish Srivastava raised his price target on Analog Devices to $107 after the company's Q1 results that were "solid on all fronts". The analyst states that B2B was strong, automotive division performed better, and the BMS business is positioned for recovery. Srivastava keeps his Outperform rating on Analog Devices, adding that his EPS estimates for FY18 and FY19 are also revised higher to account for revenue and gross margin upside as well as the lower tax rate.

TODAY'S FREE FLY STORIES

FIT

Fitbit

$5.93

0.22 (3.86%)

15:00
08/20/18
08/20
15:00
08/20/18
15:00
Options
Fitbit calls active as shares extend gains »

Fitbit calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

MMM

3M

$204.54

-0.27 (-0.13%)

, SGMS

Scientific Games

$30.45

0.85 (2.87%)

14:53
08/20/18
08/20
14:53
08/20/18
14:53
Hot Stocks
3M announces filing of touch screen technology patent infringement lawsuit »

3M (MMM) and 3M…

MMM

3M

$204.54

-0.27 (-0.13%)

SGMS

Scientific Games

$30.45

0.85 (2.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPY

Brookfield Property

$19.94

-0.15 (-0.75%)

14:49
08/20/18
08/20
14:49
08/20/18
14:49
Conference/Events
Brookfield Property management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

LCI

Lannett

$5.40

-8.1 (-60.00%)

14:49
08/20/18
08/20
14:49
08/20/18
14:49
Downgrade
Lannett rating change  »

Lannett downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 28

    Aug

AABA

Altaba

$69.92

1.74 (2.55%)

14:49
08/20/18
08/20
14:49
08/20/18
14:49
Options
Altaba Inc options imply 7.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUM

Summit Materials

$20.26

0.31 (1.55%)

14:47
08/20/18
08/20
14:47
08/20/18
14:47
Conference/Events
Summit Materials management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 23

    Aug

  • 10

    Sep

CAPL

CrossAmerica

$18.15

0.15 (0.83%)

, ANDV

Andeavor

$147.76

2.82 (1.95%)

14:46
08/20/18
08/20
14:46
08/20/18
14:46
Hot Stocks
FTC approves Alimentation Couche-Tard sale of two Minnesota fuel stations »

The Federal Trade…

CAPL

CrossAmerica

$18.15

0.15 (0.83%)

ANDV

Andeavor

$147.76

2.82 (1.95%)

ANCUF

Alimentation Couche-Tard

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$15.94

0.61 (3.98%)

14:45
08/20/18
08/20
14:45
08/20/18
14:45
Options
GameStop call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHII

PHI, Inc

$8.59

0.09 (1.06%)

14:45
08/20/18
08/20
14:45
08/20/18
14:45
Hot Stocks
Alesia Value fund reports 4.7% stake in PHI »

On August 20,Alesia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$216.05

-1.6 (-0.74%)

14:41
08/20/18
08/20
14:41
08/20/18
14:41
Periodicals
Breaking Periodicals news story on Apple »

Apple planning revamped…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCHVF

MGM China

$0.00

(0.00%)

14:36
08/20/18
08/20
14:36
08/20/18
14:36
Upgrade
MGM China rating change  »

MGM China upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:35
08/20/18
08/20
14:35
08/20/18
14:35
General news
The Fed has become an unexpected focus »

The Fed has become an…

14:35
08/20/18
08/20
14:35
08/20/18
14:35
General news
Canada wholesale preview »

Canada wholesale preview:…

CTWS

Connecticut Water

$69.10

0.1 (0.14%)

14:34
08/20/18
08/20
14:34
08/20/18
14:34
Hot Stocks
PURA approves rate settlement agreement for Connecticut Water »

Connecticut Water Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMB

Williams

$30.38

-0.095 (-0.31%)

14:30
08/20/18
08/20
14:30
08/20/18
14:30
Conference/Events
Williams management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

AMZN

Amazon.com

$1,880.70

-1.24 (-0.07%)

14:29
08/20/18
08/20
14:29
08/20/18
14:29
Periodicals
Amazon hires well-known cardiologist amid push into health, CNBC says »

Amazon has hired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

AMCX

AMC Networks

$61.70

1.28 (2.12%)

14:25
08/20/18
08/20
14:25
08/20/18
14:25
Conference/Events
AMC Networks management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 23

    Aug

OSPR

Osprey Energy Acquisition

$11.27

0.065 (0.58%)

14:25
08/20/18
08/20
14:25
08/20/18
14:25
Conference/Events
Osprey Energy Acquisition to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

PPG

PPG

$109.64

1.23 (1.13%)

14:24
08/20/18
08/20
14:24
08/20/18
14:24
Conference/Events
PPG management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 05

    Sep

NFLX

Netflix

$330.55

13.77 (4.35%)

14:21
08/20/18
08/20
14:21
08/20/18
14:21
Technical Analysis
Technical Take: Netflix may test downtrend resistance line »

The shares are up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
08/20/18
08/20
14:17
08/20/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
08/20/18
08/20
14:16
08/20/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LCI

Lannett

$5.35

-8.15 (-60.37%)

14:16
08/20/18
08/20
14:16
08/20/18
14:16
Downgrade
Lannett rating change  »

Lannett downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 28

    Aug

MBI

MBIA

$10.78

-0.22 (-2.00%)

14:15
08/20/18
08/20
14:15
08/20/18
14:15
Options
MBIA put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$30.79

0.05 (0.16%)

14:08
08/20/18
08/20
14:08
08/20/18
14:08
Hot Stocks
SEC says Merrill Lynch to pay $8.9M to settle charges of undisclosed conflict »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.